Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending June 24
McAfee, Boohoo, Carlsberg, Janus International, LaserShip, Wheels Up, JELD-WEN, LiveWire, SeaWorld, Deliveroo
By
Lauren Muskett
| June 24, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Pershing Square Capital Management
IPOs
Bill Ackman Files for Largest-Ever SPAC Offering
The investor is betting that blank-check mergers continue to be an attractive alternative to traditional IPOs amid the current market volatility.
By
Matthew Heller
| June 24, 2020
Read More
Risk & Compliance
Activist Investor Can’t Dodge Insider Trading Suit
A judge finds Bill Ackman can be sued for allegedly buying a stake in Allergan based on inside information about a takeover bid by Valeant Pharmaceuticals.
By
Matthew Heller
| November 12, 2015
Read More
Risk
Ackman’s Allergan Takeover Bid Is Easier Said Than Done
The takeover contest's outcome becomes unclear when we consider the conflict between the hedge fund’s objectives and the Allergan board's fiduciary duty.
By
Gardner Davis
| June 16, 2014
Read More
Risk
Herbalife: The House of Cards Put
Activist investing meets activist government.
By
Economist Staff
| March 14, 2014
Read More
